期刊文献+

炎症性肠病联合治疗中的药物相互作用 被引量:1

下载PDF
导出
摘要 炎症性肠病(inflammatory bowel disease,IBD)指病因未明的肠道炎症性疾病,包括溃疡性结肠炎(ulcerative colitis,UC)和克罗恩病(Crohn disease,CD)。IBD的发病率呈逐年增加的趋势[1],发病人群多为青年,IBD对患者生活质量影响大。近年来,IBD的治疗观念有所改变,认为症状控制并不是治疗目标,而更强调黏膜愈合及改变自然病程。
出处 《协和医学杂志》 2016年第3期216-219,共4页 Medical Journal of Peking Union Medical College Hospital
  • 相关文献

参考文献1

二级参考文献20

  • 1E Sim,A Abuhammad,A Ryan.Arylamine N‐acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery[J]. Br J Pharmacol . 2014 (11)
  • 2Xiang Gao,Fang-bin Zhang,Liang Ding,Hui Liu,Xue-ding Wang,Bai-li Chen,Hui-chang Bi,Ying-Lian Xiao,Li-zi Zhao,Min-hu Chen,Min Huang,Pin-jin Hu.The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients[J]. European Journal of Gastroenterology & Hepatology . 2012 (8)
  • 3B.Jharap,M.L.Seinen,N.K.H.de Boer,J.R.van Ginkel,R.K.Linskens,J.C.Kneppelhout,C.J.J.Mulder,A.A.van Bodegraven.Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8‐year intercept cohorts[J]. Inflamm Bowel Dis . 2010 (9)
  • 4PDe Graaf,NKHDe Boer,DRWong,SKarner,BJharap,PMHooymans,AIVeldkamp,CJJMulder,AAVan Bodegraven,MSchwab.Influence of 5‐aminosalicylic acid on 6‐thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy[J]. British Journal of Pharmacology . 2010 (5)
  • 5Loredana Serpe,Pier Luigi Calvo,Elisabetta Muntoni,Sergio D’,Antico,Mario Giaccone,Alessandra Avagnina,Maurizio Baldi,Cristiana Barbera,Franco Curti,Angelo Pera,Mario Eandi,Gian Paolo Zara,Roberto Canaparo.Thiopurine S -methyltransferase pharmacogenetics in a large-scale healthy Italian–Caucasian population: differences in enzyme activity[J]. Pharmacogenomics . 2009 (11)
  • 6Jayshri A. Shah,Cathryn M. Edwards,Chris S. Probert.Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome[J]. European Journal of Gastroenterology & Hepatology . 2008 (3)
  • 7C. W.LEES,A. K.MAAN,B.HANSOTI,J.SATSANGI,I. D. R.ARNOTT.Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease[J]. Alimentary Pharmacology & Therapeutics . 2007 (3)
  • 8Simon Travis.Infliximab and Azathioprine: Bridge or Parachute?[J]. Gastroenterology . 2006 (4)
  • 9Xu Zhangwei,Xu Jianming,Mei Qiao,Xu Xinhua.N -Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population[J]. Clinica Chimica Acta . 2006 (1)
  • 10L. P. L.GILISSEN,J.BIERAU,L. J. J.DERIJKS,L. P.BOS,P. M.HOOYMANS,A.GENNIP,R. W.STOCKBRüGGER,L. G. J. B.ENGELS.The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients[J]. Alimentary Pharmacology & Therapeutics . 2005 (7)

共引文献4

同被引文献59

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部